A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT05321368
- Status
- Recruiting
Conditions
- Chronic Kidney Diseases
- Diabetes
- High Blood Pressure
- Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- LINKED-HEARTS Program — BEHAVIORALThe intervention arm will include training on home blood pressure monitoring, Sphygmo blood pressure telemonitoring app, Community Health Worker visit for education, counseling on lifestyles modification and Pharmacist to collaborate with other providers to optimize pharmacologic therapy to improve hypertension outcomes and with payors to ensure consistent access to drug therapy.
Study Details
The LINKED- HEARTS Program is a multi-level project that intervenes at the practice level by linking home blood pressure monitoring (HBPM) with a telemonitoring platform (Sphygmo). The program incorporates team-based care by including community health workers (CHWs) and pharmacists to improve the outcomes of multiple chronic conditions (reduced blood pressure (BP), lower blood sugar, and improved kidney function). The LINKED-HEARTS Program will recruit a total of 600 adults with uncontrolled hypertension (BP ≥ 140/90 mm Hg) AND either type 2 diabetes or chronic kidney disease (CKD) across 16 community health centers or primary care practices serving high-risk adults. This cluster-randomized trial consists of two arms: (1) enhanced "usual care arm," wherein patients will be provided with Omron 10 series home BP monitors and will be managed by the patients' primary care clinicians as usual; and (2) the "intervention arm" which will integrate HBPM telemonitoring, a CHW intervention and provider-level interventions into the usual clinical care to improve BP control and provide support for self-management of chronic conditions. The study pharmacist will conduct telehealth, use the Sphygmo app and the Pharmacist Patient Care Process to collaborate with other providers to optimize pharmacologic therapy to improve hypertension outcomes and with payors to ensure consistent access to drug therapy.
Key Dates
- Start date
- Oct 16, 2023
- Status verified
- Oct 2025
- Primary completion
- Oct 21, 2026
- Completion
- Apr 22, 2027
Study Design
- Enrollment
- 425 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: LINKED-HEARTS ProgramPatients in the LINKED-HEARTS Program will be trained to measure their blood pressure with an Omron 10 series device using the Sphygmo telemonitoring app. The physician, pharmacist and Community Health Worker will have access to transmit data. Community Health Workers will provide education on managing blood pressure; reinforce positive blood pressure self-management behaviors; deliver knowledge and skills to promote healthy chronic conditions; assist with linking clinical and administrative services; and link participants with community resources. The study pharmacist will conduct telehealth visits, optimize pharmacologic therapy. The pharmacists will assess and address medication adherence to improve hypertension and diabetes control.
- No Intervention: Enhanced Usual CarePatients in the Enhanced Usual Care Arm, will receive care as usual from their primary care provider and will be trained to measure their blood pressure with an Omron 10 series device. The staff in each participating community health center practice will be trained in blood pressure measurement best practices.
Primary Outcome Measure
Blood Pressure Control as assessed by percentage of participants with controlled Blood Pressure [ Time Frame: 12 months ]
Central Contacts
- Yvonne Commodore-Mensah, PhD, MSH443-614-1519
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Unity Health Care | Washington D.C. | District of Columbia | 20019 | Andrew Robie, MD |
| Johns Hopkins Community Physicians | Baltimore | Maryland | 21205 | Sarah Rubin |
| Choptank Community Health Systems | Denton | Maryland | 21629 | - |
Find similar trials in Washington D.C., DC
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Urinary Vitamin C Loss in Diabetic SubjectsRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora PopulationsEnrolling By Invitation · National Human Genome Research Institute (NHGRI) · Bethesda, Maryland
- New Heart Imaging Techniques to Evaluate Possible Heart DiseaseRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland